Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Don't expect the half of $7M in PDS licenses mentioned to hit PTSC's bottom line

It doesn't matter whether the money is distributed or not. PTSC's bottom line (profit and loss) is affected by the profit/loss of PDS, whether or not any money is distributed. As an example, if PDS has a profit of $10 million, $5 million shows up on PTSC's income statement regardless of whether a dime of that profit was distributed to PTSC.

Share
New Message
Please login to post a reply